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With great interest, we have read the letter ‘Cardiac slowing
and acute tryptophan depletion: a comment on the paper by
van der Veen et al.’ by Hood et al. This letter is a comment on
a recent paper by our group (van der Veen et al. 2008)
describing the differential effects of acute tryptophan
depletion (ATD) on cardiac and electro-cortical measures of
performance monitoring. In the letter, the authors describe
two specific cases in which ATD led to serious but transient
cardiovascular side effects. These side effects involved
significant episodes of bradycardia and in both cases, extra
medical help had to be summoned. The authors present the
cases as further evidence for an important role of serotonin in
the cardiovascular system and underline the importance of
cardiovascular screening of subjects participating in ATD
procedures. We completely agree with the conclusions and
think it is important to take note of the two described cases.
However, we would like to stress that the important role
of serotonin in cardiovascular regulation is well known
(e.g., Jordan 2005; Dergacheva et al. 2007; Ramage and
Villalon 2008) and was already briefly mentioned in our
paper. Furthermore, the participants in our studies are
always thoroughly screened for cardiovascular and other
health problems. Finally, the described cases seem to be very
atypical and that the cardiovascular side effects are most
likely unrelated to the effects on heart rate in our study.
Both the described cases had cardiovascular abnormal-
ities before the start of the experiment and perhaps more
thorough screening might have led to exclusion of these
two patients. Moreover, both cases were psychiatric
patients with a history of medication use, which might
have contributed to a pre-existing cardiovascular vulnera-
bility. Besides the ATD manipulation, case 2 was also given
an infusion of the benzodiazepine antagonist flumazenil,
which might have further added to any pre-existing
vulnerabilities. Therefore, we think that the described
patients are not the typical volunteers who participate in
ATD studies, and that a combination of factors might have
added to the effects of ATD. In all the studies performed by
our group, in which we have included thoroughly screened
healthy volunteers with or without a family history of
depression, we have never encountered cardiovascular side
effects of our procedures. However, it should be noted that
we have incidentally encountered physical side effects such
as nausea and vomiting and that these side effects have led
to incidental dropout.
The described cardiovascular side effects are most likely
unrelated to the effects described in our study. There is
strong evidence for a role of serotonin in the brain circuits
involved in feedback processing (e.g., Cools et al. 2008;
Jocham and Ullsperger 2009) and cardiac responses to
feedback are highly sensitive to subtle changes in activation
in these circuits (e.g., Crone et al. 2003; van der Veen et al.
2004). Therefore, we like to argue that the cardiac effects
described in our paper are related to changes in these
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higher-order circuits. In our study, it was found that ATD
attenuated the cardiac response to negative feedback, but
did not affect the response to positive feedback. In other
words, ATD did not affect heart rate itself, but selectively
influenced the stimulus-related effect on heart rate. There-
fore, we think that it is most unlikely that this effect is
caused by peripheral changes or by influences on the lower
brain structures mentioned by Hood et al. Such effects
would have caused an undifferentiated effect of ATD and
therefore, it is more likely that changed activation in the
earlier-mentioned higher-order circuits is responsible for the
described subtle changes in the phasic cardiac responses.
Finally, in a second task that was performed by the same
group of healthy volunteers we also found a differential
effect of ATD on the cardiac response to congruent and
incongruent flanker stimuli (van der Veen et al., submitted)
which again pointed in the direction of the involvement of
higher cortical areas.
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